Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 42.56
-0.86 (-1.98%)
May 12, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 6.23 billion as of May 12, 2026. Its market cap has increased by 62.13% in one year.
Market Cap
6.23B
Enterprise Value
4.83B
Revenue
449.50M
Ranking
n/a
PE Ratio
203.49
Stock Price
42.56
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 6.23B, a decrease of -24.31%. That is a compound annual growth rate of -5.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 6.23B | 12.65% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 7.12B |
| Xiangxue Pharmaceutical | 6.99B |
| Wuhan Keqian Biology Co.,Ltd | 6.90B |
| Anhui Huaheng Biotechnology | 6.84B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.19B |
| Novogene | 6.12B |
| PharmaResources (Shanghai) | 6.11B |
| R&G PharmaStudies | 5.98B |